EICHORPublic-registry trials using BMX-010 that Eichor's radar has found — 1 trial. All data below is from public sources; Eichor is not affiliated with any sponsor.
BMX-010 appears in 1 registered trial Eichor's radar has found, sponsored by BioMimetix JV, LLC, the most recent registered as Phase 2, with a planned enrollment of 139. Registered timeline: 2018–2021. The registry holds 2,534 registered studies for Psoriasis.
| Trial | Sponsor | Condition | Phase | Sites |
| Topical Application of BMX-010 in Subjects With Atopic Dermatitis and Plaque Psoriasis | BioMimetix JV, LLC | Psoriasis | PHASE2 | 10 |
| Status | Completed · planned start 2018-01 |
| Primary completion | 2021-07 |
| Enrollment target | 139 participants |
| Design | Randomized · Parallel · Phase 2 · 2 arms |
| Who it enrolls | All sexes · 18 Years and older — full criteria are on the study record |
| Locations | 10 listed in United States |
All fields verbatim from the ClinicalTrials.gov record for NCT03381625.
| First registered study | May 2015 — NCT02457858 (University of Alberta) |
| Registered studies matching this name | 5 all-time · 0 currently recruiting |
Source: ClinicalTrials.gov, the public trial registry.
The public registry holds 2,534 registered studies for Psoriasis. Compounds appearing across the 200 most recently updated registry entries:
Eichor generates a preliminary site-risk snapshot — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →
Trialed alongside
← Eichor home · All tracked trials · Psoriasis studies · Weekly briefs
